To learn more about Madrigal, our programs and partnership opportunities, please complete the form below and we will be in touch.

Corporate Headquarters

Madrigal is a clinical-stage biopharmaceutical company developing a potential first-to-market novel therapy for patients with non-alcoholic steatohepatitis (NASH) and liver fibrosis.